Fellow Spotlight - April 2018
Dr. Nicole Kettner (Keyomarsi Laboratory) was awarded a U.S. Department of Defense Breast Cancer Research Program (DoD BCRP) Breakthrough Fellowship Award. Her award: "BC170615: Mechanisms of Action and Resistance to CDK4/6 Inhibitors in Breast Cancer" was was one of only seven selected from highly competitive and top programs around the nation. This 3-year fellowship award provides $480,000 in research funding for Dr. Kettner's research.
Congrats to Nicole for earning this prestigious award.
CPRIT TRIUMPH Fellows
Nicole Kettner, B.S., Ph.D.
Khandan Keyomarsi Laboratory
CPRIT TRIUMPH Fellow 2016-2017, 2017-2018
Dr. Kettner earned her bachelor's degree from Winona State University, where her senior undergraduate research project studied the mechanism of Sbp1p mediated translational repression in S. cerevisiae under the mentorship of Dr. Scott Segal. She continued on to earn her Ph.D. at Baylor College of Medicine in Dr. Loning Fu's laboratory. Here, Dr. Kettner studied the role of the mammalian circadian clock in metabolism and tumor suppression. She completed a short postdoctoral fellowship in Dr. Fu's laboratory to complete a project focused on the role of circadian disruption in metabolic syndrome-induced spontaneous hepatocarcinogenesis before coming to MD Anderson Cancer Center to work on her current project with Dr. Keyomarsi.
Dr. Kettner's Research Interests:
My research project focuses on identifying the biological mechanism(s) of the resistance to CDK4/6 inhibitors and to identify independent biomarkers to predict response and/or resistance.
Nabiollah Kamyabi, B.S., M.S., Ph.D.
Anirban Maitra Laboratory
CPRIT TRIUMP Fellow 2017-2018
Dr. Kamyabi earned his Bachelors and Masters of Science Degrees at Sharif University of Technology in Tehran, Iran. He continued his studies to earn his Ph.D. in Chemical Engineering at Texas Tech University before accepting his TRIUMPH Postdoctoral Fellowship position at MD Anderson Cancer Center.
Dr. Kamyabi's Research Interests:
I work on engineering devices for in vitro metastatic models of cancer and high-throughput drug screening.